Key EventDirector Sanjay Bansal sold 70,000 equity shares on September 28, 2026.
Medicamen Biotech Ltd (MEDICAMEQ)
·Next Day Close·-1.52%·₹324
Key EventTrading window closed for insider transactions
ImpactShareholders must avoid trading during the closed window to prevent insider trading violations.Sign up to read impact
Medicamen Biotech Ltd (MEDICAMEQ)
·Next Day Close·-1.52%·₹324
Key Event33rd AGM of Medicamen Biotech approved all resolutions including financial statements and director reappointments
ImpactShareholders broadly endorsed management proposals with near-unanimous approval, signaling no significant governance or strategic shifts.Sign up to read impact
Medicamen Biotech Ltd (MEDICAMEQ)
·Next Day Close·+3.12%·₹329
Key Event33rd AGM held on 26 September 2026 via video conference
ImpactShareholders approved financial statements, dividend, and director reappointments, signaling confidence in the company's current strategy and governance.Sign up to read impact
Medicamen Biotech Ltd (MEDICAMEQ)
·Next Day Close·+3.92%·₹270.55
Key Event33rd AGM approved FY2025-26 financials and related party transactions
ImpactThe company is focused on sustainable growth in oncology and international markets with strong financials and approved related party transactions for future expansionSign up to read impact
Medicamen Biotech Ltd (MEDICAMEQ)
·Next Day Close·+3.92%·₹270.55
Key EventMedicamen Biotech Ltd announces 33rd AGM on September 26, 2026 and files FY 2025-26 Annual Report with financial results and governance updates.
ImpactThe company demonstrated strong financial growth and strategic expansion while maintaining governance compliance, with a recommended ₹1 per share dividend for shareholders.Sign up to read impact
Medicamen Biotech Ltd (MEDICAMEQ)
·Next Day Close·+3.92%·₹270.55
Key EventMedicamen Biotech submits BRSR report to BSE for FY 2025-26
ImpactThe BRSR filing confirms Medicamen's commitment to ESG compliance, with measurable progress in export-driven growth, CSR execution, and environmental stewardship, though full CSR targets remain partially unmet.Sign up to read impact
Medicamen Biotech Ltd (MEDICAMEQ)
·Next Day Close·+3.92%·₹270.55
Key Event33rd AGM scheduled for September 26, 2026, with preferential share issue and director appointments
ImpactThe company is expanding its oncology portfolio and international presence while facing governance penalties that require corrective actions.Sign up to read impact
Medicamen Biotech Limited (MEDICAMEQ)
·Next Day Close·+1.42%·₹229.15
Key EventAGM scheduled for September 19, 2026
ImpactShareholders must be registered by September 19 to receive any declared final dividend.Sign up to read impact
Medicamen Biotech Limited (MEDICAMEQ)
·Next Day Close·-1.55%·₹235.25
Key EventCertificate filed under SEBI Regulation 74(5) for Q1 FY2026.